Predictive Oncology Inc. (POAI): Price and Financial Metrics
POAI Price/Volume Stats
| Current price | $1.34 | 52-week high | $7.12 |
| Prev. close | $1.29 | 52-week low | $1.12 |
| Day low | $1.29 | Volume | 24,438 |
| Day high | $1.37 | Avg. volume | 26,915 |
| 50-day MA | $2.48 | Dividend yield | N/A |
| 200-day MA | $3.41 | Market Cap | 5.44M |
POAI Stock Price Chart Interactive Chart >
Predictive Oncology Inc. (POAI) Company Bio
Predictive Oncology Inc. operates as a biotechnology company. The Company focuses focuses on applying data and artificial intelligence to personalized medicine and drug discovery. Predictive Oncology serves customers worldwide.
Latest POAI News From Around the Web
Below are the latest news stories about PREDICTIVE ONCOLOGY INC that investors may wish to consider to help them evaluate POAI as an investment opportunity.
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business UpdateCompany to host investor call and webcast today, November 14th, at 8:30am EDTPITTSBURGH, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility, to accelerate oncologic drug discovery and enable drug development, today reported financial and operating results for the three and nine months ended Sep |
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens HospitalPITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study with UPMC Magee-Womens Hospital. The objective of the study was to evaluate the use of AI to build multi-omic machine learning (ML) models and test if these models can learn associations between the datasets and ovarian cancer patient short- and long-term survival. “This study incorporated one of the la |
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023Management to host conference call and webcast at 8:30am EDTEAGAN, Minn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced that |
3 AI Stocks Worth Buying Now for Multibagger ReturnsWith no signs of artificial intelligence cooling, we could be looking at a potential $1.8 trillion opportunity for AI stocks. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday! |
POAI Price Returns
| 1-mo | -48.66% |
| 3-mo | -55.63% |
| 6-mo | -53.15% |
| 1-year | -56.98% |
| 3-year | -93.80% |
| 5-year | -99.09% |
| YTD | -59.27% |
| 2023 | -46.35% |
| 2022 | -67.79% |
| 2021 | 29.97% |
| 2020 | -71.94% |
| 2019 | -57.90% |
Loading social stream, please wait...